Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Dermatology

  Free Subscription


29.01.2018

19 Br J Dermatol
7 Cutis
7 Int J Dermatol
3 J Cutan Pathol
5 J Dermatol
3 Lancet Oncol
3 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Br J Dermatol

  1. MUTHIAH S, Tang D, Nasr B, Verykiou S, et al
    A new era in holistic care: bridging the gap between dermatologists and oncologists for the treatment of malignant melanoma.
    Br J Dermatol. 2018;178:1-4.
    PubMed     Text format    

  2. NALDI L
    Biologic treatment for psoriasis and cancer: an increased risk for most cancers could not be ruled out.
    Br J Dermatol. 2018;178:19.
    PubMed     Text format    

  3. SILLING S, Akgul B
    Treatment success in cutaneous warts: morphology and human papillomavirus type matter.
    Br J Dermatol. 2018;178:30-31.
    PubMed     Text format    

  4. SEKHON S, Koo J
    Indirubin: a novel topical agent in the treatment of psoriasis.
    Br J Dermatol. 2018;178:21.
    PubMed     Text format    

  5. WEHNER MR
    Sunscreen and melanoma prevention: evidence and expectations.
    Br J Dermatol. 2018;178:15-16.
    PubMed     Text format    

  6. BORSARI S, Pampena R, Benati E, Bombonato C, et al
    In vivo dermoscopic and confocal microscopy multi-step algorithm to detect in situ melanomas.
    Br J Dermatol. 2018 Jan 21. doi: 10.1111/bjd.16364.
    PubMed     Text format     Abstract available

  7. STULL DE, Griffiths CEM, Gilloteau I, Zhao Y, et al
    Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis.
    Br J Dermatol. 2018 Jan 21. doi: 10.1111/bjd.16366.
    PubMed     Text format     Abstract available

  8. CHABY G, Valeyrie-Allanore L, Duong TA, Lebrun-Vignes B, et al
    Severe cutaneous adverse reactions due to inappropriate medication use.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16365.
    PubMed     Text format     Abstract available

  9. MARONAS-JIMENEZ L, Ortiz-Romero PL
    Aprepitant did not modify global disease activity in cutaneous T cell lymphomas.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16374.
    PubMed     Text format     Abstract available

  10. KWATRA SG, Boozalis E, Kwatra MM
    Effects of neuroimmune axis modulation by aprepitant on anti-pruritic and global disease severity in patients with cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16363.
    PubMed     Text format     Abstract available

  11. WIESNER T, Zbyszewski A
    Progress in the diagnosis and therapy of melanoma.
    Br J Dermatol. 2018;178:12-14.
    PubMed     Text format    

  12. RENCZ F
    Patients with psoriasis on a new trajectory: long-term improvement in quality of life with biologics.
    Br J Dermatol. 2018;178:29-30.
    PubMed     Text format    

  13. TSCHANDL P, Wiesner T
    Advances in the diagnosis of pigmented skin lesions.
    Br J Dermatol. 2018;178:9-11.
    PubMed     Text format    

  14. MILLINGTON GWM, Collins A, Lovell CR, Leslie TA, et al
    British Association of Dermatologists' guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018.
    Br J Dermatol. 2018;178:34-60.
    PubMed     Text format    

  15. SANCLEMENTE G
    What can we learn from psoriasis pharmacogenomics research?
    Br J Dermatol. 2018;178:17.
    PubMed     Text format    

  16. PRINSEN CAC
    T-QoL: a quality of life outcome measure specifically developed for adolescents with skin diseases.
    Br J Dermatol. 2018;178:23-25.
    PubMed     Text format    

  17. CHASSET F, Haroche J
    Cutaneous manifestations of paediatric Erdheim-Chester disease, a histiocytosis of the 'L' group.
    Br J Dermatol. 2018;178:31-32.
    PubMed     Text format    

  18. VERYKIOU S, Edwards N, Hill D
    How breakthroughs in translational research have impacted treatment strategies for melanoma.
    Br J Dermatol. 2018;178:5-8.
    PubMed     Text format    

  19. KHOURY LR, Moller T, Zachariae C, Skov L, et al
    A prospective 52-week randomised controlled trial of patient-initiated care consultations for patients with psoriasis.
    Br J Dermatol. 2018 Jan 24. doi: 10.1111/bjd.16369.
    PubMed     Text format     Abstract available


    Cutis

  20. CALLENDER VD, Barbosa V, Burgess CM, Heath C, et al
    Approach to treatment of medical and cosmetic facial concerns in skin of color patients.
    Cutis. 2017;100:375-380.
    PubMed     Text format     Abstract available

  21. KNISLEY RR, Petropolis AA, Mackey VT
    Lichen planus pemphigoides treated with ustekinumab.
    Cutis. 2017;100:415-418.
    PubMed     Text format     Abstract available

  22. PILKINGTON S, McKinley LH, Miller RA
    Pediatric nevoid basal cell carcinoma syndrome.
    Cutis. 2017;100:423-426.
    PubMed     Text format     Abstract available

  23. LANDERO J
    Long-term pubic dermatitis diagnosed as white piedra.
    Cutis. 2017;100:448-450.
    PubMed     Text format     Abstract available

  24. KELLEN R, Silverberg NB
    Pediatric periorificial dermatitis.
    Cutis. 2017;100:385-388.
    PubMed     Text format     Abstract available

  25. SOTOODIAN B, Kuzel P, Brassard A, Fiorillo L, et al
    Disfiguring ulcerative neutrophilic dermatosis secondary to doxycycline and isotretinoin in an adolescent boy with acne conglobata.
    Cutis. 2017;100:E23-E26.
    PubMed     Text format     Abstract available

  26. LAI YC, Yew YW
    Lichen planus and lichenoid drug eruption after vaccination.
    Cutis. 2017;100:E6-E20.
    PubMed     Text format     Abstract available


    Int J Dermatol

  27. DUNDAR Y, Cannon RB, Hunt JP, Monroe M, et al
    Radiotherapy regimens in patients with nonmelanoma head and neck skin cancers.
    Int J Dermatol. 2018 Jan 22. doi: 10.1111/ijd.13879.
    PubMed     Text format     Abstract available

  28. SGNOTTO FDR, de Oliveira MG, Lira AAL, Inoue AHS, et al
    IgG from atopic dermatitis patients induces IL-17 and IL-10 production in infant intrathymic TCD4 and TCD8 cells.
    Int J Dermatol. 2018 Jan 22. doi: 10.1111/ijd.13907.
    PubMed     Text format     Abstract available

  29. ALCALA R, March A, Arumi M, Pujol RM, et al
    Chronic pruritic warty papules on the buttocks.
    Int J Dermatol. 2018 Jan 22. doi: 10.1111/ijd.13915.
    PubMed     Text format    

  30. ROY SF, Ghazawi FM, Veilleux B, Bouffard D, et al
    A rare cause of blanching red legs: cutaneous collagenous vasculopathy.
    Int J Dermatol. 2018 Jan 23. doi: 10.1111/ijd.13900.
    PubMed     Text format    

  31. JIANG YY, Nguyen GH, Jin HZ, Zeng YP, et al
    Methazolamide-induced toxic epidermal necrolysis in a man carrying HLA-B*59:01: successful treatment with infliximab and glucocorticoid.
    Int J Dermatol. 2018 Jan 23. doi: 10.1111/ijd.13924.
    PubMed     Text format    

  32. NAVARRO-TRIVINO FJ, Munoz-Medina L, Navarro-Navarro I, Ruiz-Villaverde R, et al
    Cutaneous eruptions by new therapies against hepatitis C virus infection. Not as common as we presumed.
    Int J Dermatol. 2018 Jan 23. doi: 10.1111/ijd.13882.
    PubMed     Text format    

  33. KRIEGER Y, Wainstock T, Sheiner E, Harlev A, et al
    Long-term pediatric skin eruption-related hospitalizations in offspring conceived via fertility treatment.
    Int J Dermatol. 2018 Jan 25. doi: 10.1111/ijd.13903.
    PubMed     Text format     Abstract available


    J Cutan Pathol

  34. GALVEZ A, Sperling L
    Lichen planopilaris and frontal fibrosing alopecia cannot be differentiated by histopathology.
    J Cutan Pathol. 2018 Jan 25. doi: 10.1111/cup.13112.
    PubMed     Text format     Abstract available

  35. KAILAS A, Elston DM, Crater SE, Cerruto CA, et al
    Cutaneous Intravascular CD30+ T-cell Pseudolymphoma Occurring in a Regressing Keratoacanthoma.
    J Cutan Pathol. 2018 Jan 25. doi: 10.1111/cup.13111.
    PubMed     Text format     Abstract available

  36. FERNANDEZ-FLORES A, Llamas-Velasco M, Saus C, Patel A, et al
    Microcystic adnexal carcinoma with sebaceous differentiation: three cases.
    J Cutan Pathol. 2018 Jan 20. doi: 10.1111/cup.13109.
    PubMed     Text format     Abstract available


    J Dermatol

  37. OBARA K, Masuzawa M, Amoh Y
    Oral lichenoid reaction showing multiple ulcers associated with anti-programmed death cell receptor-1 treatment: A report of two cases and published work review.
    J Dermatol. 2018 Jan 20. doi: 10.1111/1346-8138.14205.
    PubMed     Text format     Abstract available

  38. WADA T, Toma T, Miyazawa H, Koizumi E, et al
    Characterization of skin blister fluids from children with Epstein-Barr virus-associated lymphoproliferative disease.
    J Dermatol. 2018 Jan 20. doi: 10.1111/1346-8138.14226.
    PubMed     Text format     Abstract available

  39. LIU JM, Lin CY, Chang FW, Liu YP, et al
    Increased risk of psoriasis following scabies infection: A nationwide population-based matched-cohort study.
    J Dermatol. 2018 Jan 21. doi: 10.1111/1346-8138.14221.
    PubMed     Text format     Abstract available

  40. ICHIYAMA S, Ito M, Funasaka Y, Abe M, et al
    Assessment of medication adherence and treatment satisfaction in Japanese patients with psoriasis of various severities.
    J Dermatol. 2018 Jan 21. doi: 10.1111/1346-8138.14225.
    PubMed     Text format     Abstract available

  41. MORITA A
    Current developments in phototherapy for psoriasis.
    J Dermatol. 2018 Jan 25. doi: 10.1111/1346-8138.14213.
    PubMed     Text format     Abstract available


    Lancet Oncol

  42. ASCIERTO PA, Eggermont AMM
    Neoadjuvant therapy in melanoma: the next step?
    Lancet Oncol. 2018 Jan 17. pii: S1470-2045(18)30016.
    PubMed     Text format    

  43. AMARIA RN, Prieto PA, Tetzlaff MT, Reuben A, et al
    Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
    Lancet Oncol. 2018 Jan 17. pii: S1470-2045(18)30015.
    PubMed     Text format     Abstract available

  44. BEAVER JA, Hazarika M, Mulkey F, Mushti S, et al
    Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis.
    Lancet Oncol. 2018 Jan 17. pii: S1470-2045(17)30846.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  45. DARASH-YAHANA M, Pozniak Y, Lu M, Sohn YS, et al
    Breast cancer tumorigenicity is dependent on high expression levels of NAF-1 and the lability of its Fe-S clusters.
    Proc Natl Acad Sci U S A. 2016 Sep 12. pii: 201612736.
    PubMed     Text format     Abstract available

  46. EVANS KK, Haygood TM, Cooper J, Culpan AM, et al
    A half-second glimpse often lets radiologists identify breast cancer cases even when viewing the mammogram of the opposite breast.
    Proc Natl Acad Sci U S A. 2016 Aug 29. pii: 201606187.
    PubMed     Text format     Abstract available

  47. HOLL EK, Shumansky KL, Borst LB, Burnette AD, et al
    Scavenging nucleic acid debris to combat autoimmunity and infectious disease.
    Proc Natl Acad Sci U S A. 2016 Aug 15. pii: 201607011.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: